2018 International Congress Archives - Page 117 of 177

C-spine injury with progressive gait difficulty, drop foot, bizarre gait and serum positive stiff person syndrome: A case report

K.W. Chen, K.L. Ho, A.C. Chen, J.J. Lin (Taichung, Taiwan)
Can a novel digital pen system assist clinicians in the differential diagnosis of Parkinson’s disease?

M. Agarwal, K. Vallely, R. Zietsma, W. Gray, R. Walker (Newcastle upon Tyne, United Kingdom)
Can blood biomarkers differentiate Idiopathic Parkinson’s disease from Parkinson plus syndromes? A study from North Indian population

R. Shree, M. Mulagala, M. Modi, S. Mehta, M. Goyal, B. Medhi, V. Lal, B. Mittal (Chandigarh, India)
Can brittle dyskinesia be one of the causes of Twiddler syndrome in Deep Brain Stimulation?

A. Acarer, H. Biçeroğlu, T. Yurtsever, Z. Çolakoğlu (Izmir, Turkey)
Can cerebellar dysfunction help differentiate idiopathic from functional cervical dystonia?

A. Stephan, D. Benninger (Lausanne, Switzerland)
Can choice of games influence the therapeutic results obtained by training in virtual reality for gait improvement in people with Parkinson’s disease?

P. Barbosa, A. da Costa, A. Falconi, M. d'Alencar, M E. Piemonte (São Paulo, Brazil)
Can Preoperative Dopamine Transporter Imaging Predict the Long-Term Outcome of Deep Brain Stimulation in Patients with Parkinson’s Disease?

B. Thomsen, S. Jensen, A. Clausen, M. Karlsborg, E. Brødsgaard, L. Friberg, M. Lonsdale, A. Løkkegaard (Copenhagen, Denmark)
Carbon Monoxide Poisoning-Induced Parkinsonism: A Prospective Study of Clinical and Neuroimage Correlation

J-Y. Li, M-C. Chou, P-H. Lai (Kaohsiung, Taiwan)
Cardiac sympathetic denervation can predict the wearing-off phenomenon in patients with Parkinson’s disease

S. Yoo, JS. Kim, JE. Lee, KS. Lee (Seoul, Republic of Korea)
Caregiver Burden in a Multidisciplinary MSA Clinic

M. Salinas, E. Kent, S. Vernino, P. Khemani (Dallas, TX, USA)
Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism

M. Bhargava, S. Bhargava (Kanpur, India)
Case of Friedreich’s ataxia with extremely large repeat expansion without systemic disease

K. Niotis, H. Ellsworth, J. Weaver, H. Sarva (New York, NY, USA)
Case report of hyperglycemic nonketotic chorea with rapid radiological resolution

T. Herath (Colombo, Sri Lanka)
Case series of Holmes tremor at the Clinical Hospital of State University of Campinas

F. de Moraes, F. de Paula, S. Filho, P. de Azevedo, L. Piovesana (Campinas, Brazil)
CASPR2 antibody mediated autoimmune encephalitis presenting with profound chorea

S. Scotton, F. Manfredonia, P. Newman (Coventry, United Kingdom)
Catecholamines interrelation in plasma of early diagnosed treatment-naive patients with Parkinson disease

D. Khasanova, Z. Zalyalova, M. Ugrumov (Kazan, Russian Federation)
Categorising visual hallucinations in early Parkinson’s disease

B. Clegg, G. Duncan, T. Khoo, R. Barker, D. Burn, A. Yarnall, R. Lawson (Newcastle upon Tyne, United Kingdom)
Caudate nucleus atrophy as an early finding of Neuroferritinopathy

G. Alvarez Bravo, J. Fernández Carril, E. Orts Castro (Guadalajara, Spain)
Cell and animal models lacking RAB39B show biochemical and behavioural phenotypes that model aspects of Parkinson’s disease

Y. Gao, G. Wilson, S. Stephenson, K. Bozaoglu, M. Dottori, P. Thomas, P. Lockhart (Melbourne, Australia)
Cerebellar Ataxia as a Manifestation of Hashimoto Encephalopathy

S. Thakolwiboon, D. Ruthirago, V. Senanarong (Lubbock, TX, USA)
Cerebellar Ataxia case series study from southern Spain: Clinical and molecular description

A. Adarmes Gomez, S. Jesus Maestre, C. Mendez delBarrio, D. Macias Garcia, F. Carrillo Garcia, M. Carballo, P. Gomez Garre, P. Mir Rivera (Seville, Spain)
Cerebellar atrophy in different motor and non-motor subtypes of Parkinson’s disease

XX. Ma, CM. Li, W. Su, HB. Chen (Beijing, China)
Cerebellar signs in progressive supranuclear palsy

D. Crosiers, A. Sieben, J. Baets, J.J. Martin, P. Cras (Edegem, Belgium)
Cerebellar tDCS modulates negative emotions recognition in Parkinson’s disease

F. Ruggiero, F. Cortese, M. Nigro, T. Bocci, L. Borellini, M. Vergari, F. Mameli, A. Priori, R. Ferrucci (Milano, Italy)
Cerebello-spinal stimulation in neurodegenerative ataxia: A randomized, double-blind, sham-controlled, crossover trial

A. Benussi, V. Dell'Era, V. Cantoni, E. Bonetta, R. Grasso, R. Manenti, M. Cotelli, A. Padovani, B. Borroni (Brescia, Italy)
Cerebral and pulmonary thromboembolism in a patient with hyperhomocystinemia treated with high dose levodopa/carbidopa intestinal gel

E. Saka Topcuoglu, L. Mehdikhanova, E. Arsava, M. Topcuoglu, B. Elibol (Ankara, Turkey)
Cerebrospinal fluid flow dynamics in Huntington’s disease evaluated by phase contrast MRI

F. Rodrigues, L. Byrne, E. De Vita, E. Johnson, N. Hobbs, J. Thornton, R. Scahill, E. Wild (London, United Kingdom)
Cerebrospinal fluid levels of cytokines in multiple system atrophy: A cross-sectional study of the atalan msa registry (CMSAR)

Y. Compta, S. Dias, M. Pulido-Salgado, D. Giraldo, A. Pérez-Soriano, M. Fernández, A. Cámara, P. Bravo, E. Muñoz, J. Saura, MJ. Marti (Barcelona, Spain)
Cerebrospinal fluid protein biomarkers in PD patients after DBS-STN surgery: A retrospective analysis of patients that underwent surgery between 1993 and 2001

R. Constantinescu, K. Blennow, L. Rosengren, B. Eriksson, T. Gudmundsdottir, Y. Jansson, A. Renck, F. Bergquist (Gothenburg, Sweden)
Cerebrospinal fluid proteomics reveals alterations of the renin-angiotensin system in Huntington’s disease

V. Niemelä, J. Sundblom, A.M. Landtblom, D. Nyholm (Uppsala, Sweden)
Cerebrotendinous Xanthomatosis: A heterogeneous condition

D. Cerdán, B. Fernández, J. Eguizábal, P. Gil, A. Mendoza, A. Castrillo, F. Rodríguez, C. Tabernero, J. Duarte (Segovia, Spain)
Cerebrotendinous Xanthomatosis: A Rare Lipid Storage Disease

H. Hanagasi, G. Yunisova, B. Bilgic, O. Dogu, H. Kaleagasi, Z. Tufekcioglu, E. Lohmann, H. Gurvit, M. Emre (Istanbul, Turkey)
Cervical dystonia – changes in resting state cerebellar connectivity induced by botulinum toxin

M. Nevrlý, P. Hok, P. Otruba, M. Kaiserová, L. Hvizdošová, Z. Tüdös, P. Hluštík, P. Kaňovský (Olomouc, Czech Republic)
Cervical dystonia in Modigliani’s paintings: The clue was the sensory trick

J.C. Martinez Castrillo, A. Alonso Canovas, P.J. Garcia (Madrid, Spain)
Cervical dystonia presentation and associated injection practices for patients undergoing routine treatment with abobotulinumtoxinA over 1 year of follow-up

R. Trosch, V. Misra, S. Om, P. Maisonobe (Farmington Hills, MI, USA)
Cervical dystonia priori to ataxia in spinocerebellar ataxia type 3 patients

X.Q. Yuan, R. Dutta, H.F. Shang (Chengdu, China)
Challenging mitochondria in idiopathic Parkinson‘s disease fibroblasts

P. Antony, O. Boyd, K. Mommaerts, K. Sokolowska, M. Ostaszewski, A. Baumuratov, L. Longhino, F. Poulain, R. Krueger, R. Balling, N. Diederich (Belvaux, Luxembourg)
Change of Cognition Functions after Subthalamic Nucleus-Deep Brain Stimulationin in Parkinson’s Disease

L. Wu, L. Chen (Guangzhou, China)
Change of tremor dominant body side after deep brain stimulation in patients with Parkinson’s disease

P. Wouters, M. Janssen, P. Kubben, L. Ackermans, Y. Temel, M. Kuijf (Maastricht, Netherlands)
Changes detected in swallowing function in Friedreich ataxia over 12 months

M. Keage, M. Delatycki, J. Dyer, L. Corben, A. Vogel (Carlton, Australia)
Changes in balance and gait after a single session of combined cerebellum and primary motor cortex transcranial direct current stimulation (tDCS) in a person with SCA1

M. León, P. Chaná (Santiago, Chile)
Changes in brain network activation (BNA) in patients with fragile x-associated tremor/ataxia syndrome (FXTAS)

T. Fay Karmon, S. Israeli-Korn, G. Yahalom, G. Issachar, Y. Yahav, A. Geva, Z. Peremen, S. Hassin-Baer (Ramat Gan, Israel)
Changes in chest wall intermuscular coherence and speech breathing kinematics during speech and non-speech tasks following LSVT LOUD® in children with dysarthria secondary to cerebral palsy

M. Ho, A. Reed, B. Mager, H. Gynane, R. Bakhtiari, C. Fox, C. Boliek (Edmonton, AB, Canada)
Changes in cortical thickness in patients with early Parkinson’s disease at different Hoehn and Yahr stages

Y. Gao, K. Nie, M. Mei, M. Guo, Z. Huang, L. Wang, J. Zhao, B. Huang, Y. Zhang, L. Wang (Guangzhou, China)
Characteristics in relation to demographic, disease related and clinical variables of a cohort of Parkinson’s disease patients from Northern Sri Lanka

A. Keshavaraj, S. Kunathilagam (Jaffna, Sri Lanka)
Characteristics of brain mri in patient with Parkinson’s disease

K. Merryn, A. Shahab, R. Faisal, S. Marisdina, E. Bahar (Palembang, Indonesia)
Characteristics of dopaminergic treatments in advanced Parkinson’s before levodopa-carbidopa intestinal gel infusion: Data from 107 tested patients

J. Szasz, V. Constantin, K. Orban-Kis, L. Bancu, D. Georgescu, J. Szederjesi, I. Mihaly, S. Szatmari (Tirgu Mures, Romania)
Characteristics of leg tremors on standing in primary orthostatic tremor and Parkinson’s disease

J. Tashiro, H. Ohtsuka, M. Hirotani, S. Hamada, H. Soma, M. Nonaka, S. Honma, K. Hamada, A. Takei, F. Moriwaka, K. Tashiro (Sapporo, Japan)
Characterization of color vision impairment in Lewy Body Diseases

T. Tousi, F. Flanigan, K. Khosravi (Cleveland, OH, USA)
Characterization of the gastrointestinal dysfunction in mice overexpressing the human mutation (A53T) of alpha-synuclein

S. Diwakarla, R. Constable, O. Artaiz, D. Finklestein, J. Berger, J. Furness (Melbourne, Australia)
Characterization of the preclinical model parkinQ311X

A. Ciammola, M. Regoni, D. Mercatelli, L. Croci, G. Serratto, S. Fasano, L. Murru, S. Novello, M. Pingue, V. Silani, G. Consalez, F. Valtorta, M. Passafaro, M. Morari, J. Sassone (Milan, Italy)
Characterizing Bulbar Dysfunction in X-Linked Dystonia-Parkinsonism (XDP): A Pilot Study

J. de Guzman, B. Perry, C. Go, J. Green, N. Sharma (Boston, MA, USA)
Characterizing the spectrum of Non-motor Symptoms in Progressive Supranuclear Palsy

C. S P, V. Holla, S. Prasad, A. Stezin, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)
Chinese patients with Wilson disease and the treatments: exampled with Unithiol (DMPS) intravenous infusion

X.P. Wang (Shanghai, China)
Chitotriosidase is a biomarker for Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)

S. Hayer, J. Böhringer, L. Schöls (Tübingen, Germany)
Chlorogenic acid exerts anti-neuroinflammatory effect by suppressing NF-κB pathway in Parkinsonian mice model

S. Singh, S. Rai, H. Birla, W. Zahra, S. Singh (Varanasi, India)
Choice for deep brain stimulation in Parkinson’s disease: Italian survey study

R. Ferrucci, C. Di Nuzzo, F. Ruggiero, F. Mancini, A. Priori (Milan, Italy)
Cholinergic basal forebrain and hippocampal structure influence visuospatial function in Parkinson’s disease

R. Berlot, S. Brezovar, B. Koritnik, Z. Pirtošek, N. Ray (Ljubljana, Slovenia)
Chorea and Ataxia as Manifestations of Xeroderma Pigmentosum: A Case Report

A. Jocson, K. Ngo, D. Togasaki, B. Fogel (Los Angeles, CA, USA)
Choreaathetosis as clinical manifestation of Fahr Syndrome inTurner Syndrome Patient

S. Marisdina, M. Mukhlisa, K. Merryn (Palembang, Indonesia)
Chronological view of peak and diphasic dyskinesia, wearing off and freezing in Parkinson’s disease: 1212 Korean population

Y.E. Kim, B. Jeon. (Anyang, Republic of Korea)
Circadian modifications in Parkinson disease

S. Guo (Wuhan, China)
Classification of Dopaminergic-State and Motor Activity by Theta, Beta and Gamma Activity in Parkinson’s Disease

I. Weber, C. Oehrn, N. Apetz, T. Dembek, F. Jung, E. Florin, L. Timmermann (Marburg, Germany)
Classifying carriers of the G2019S mutation in the LRRK2 gene using MRI radiomics analysis

M. Artzi, A. Thaler, A. Orr Urterger, T. Hendler, M. Sela, A. Mirelman, D. Ben Bashat (Tel Aviv, Israel)
Classifying Parkinsonian Gait and Turning in Daily Life with Wearable Technology

F. Horak, J. McNames, M. El Gohary, J. Nutt, C. Curtze (Portland, OR, USA)
Clinical and functional network features of visuoperceptual disturbances in Parkinson’s disease

K. Kawabata, H. Watanabe, R. Ohdake, K. Hara, E. Bagarinao, T. Kato, A. Ogura, M. Masuda, T. Yokoi, T. Tsuboi, M. Katsuno, G. Sobue (Nagoya, Japan)
Clinical and genetic data of Huntington disease in Uzbekistan patient

M. Rakhimova (Tashkent, Uzbekistan)
Clinical and genetic heterogeneity in portuguese patients with Hereditary Spastic Paraplegia

I. Cunha, A. Brás, J. Ribeiro, C. Januário (Coimbra, Portugal)
Clinical and genetics characterization of patients with Myoclonus Dystonia Syndrome

B. Perez-Dueñas, M. Vanegas, L. Marti, A. Darling, D. Ortigoza-Escobar, S. Candela, H. Baide, J. Campistol, S. Aguilera, M. Marti, A. Macaya (Barcelona, Spain)
Clinical and imaging progression in the PARS cohort: Results from 6 years of observation

D. Jennings, A. Siderowf, S. Eberly, D. Oakes, M. Stern, K. Marek (New Haven, CT, USA)
Clinical and Molecular Characterization of a Family with Ataxia with Oculomotor Apraxia Type 2

T. Tropea, N. Jain, T. Unger, A. Chen-Plotkin. (Philadelphia, PA, USA)
Clinical and morphometric features of the tics

S. Munasipova, Z. Zalyalova (Kazan, Russian Federation)
Clinical and mutation spectrum of Ataxia with oculomotor apraxia-2: An Indian perspective

S. Shakya, M. Faruq, A. Srivastava, I. Singh, A. Garg, R. Rajan, V. Goyal (New Delhi, India)
Clinical characteristics of a family harbouring a novel CCDC88C mutation (SCA40)

W. Nachbauer, E. Indelicato, A. Eigentler, S. Boesch (Innsbruck, Austria)
Clinical characteristics of frailty in Parkinson’s disease

M. Peball, P. Mahlknecht, M. Werkmann, K. Marini, F. Murr, H. Herzmann, H. Stockner, R. de Marzi, B. Heim, A. Djamshidian, P. Willeit, J. Willeit, S. Kiechl, M. Nocker, K. Mair, W. Poewe, K. Seppi (Innsbruck, Austria)
Clinical Characteristics of Functional Movement Disorders: A Clinic-Based Study

J. Park (Goyang, Republic of Korea)
Clinical characteristics of turkish patients with Parkinson’s disease: A retrospective analysis of 428 patients

B. Gonenli Kocer, E. Ozturk, S. Comoglu (Ankara, Turkey)
Clinical characterization of Pramipexole induced edema and skin reaction in Parkinson’s Disease (PD) after one year of follow up

E. Urrea-Mendoza, N. Rincon, F. Revilla (Greenville, SC, USA)
Clinical characterization of tremor in patients with Phenylketonuria (PKU)

F. Nardecchia, F. Manti, S. De Leo, C. Carducci, V. Leuzzi (Rome, Italy)
Clinical correlates of stuttering in advanced Parkinson’s disease

T. Tsuboi, H. Watanabe, Y. Tanaka, R. Ohdake, M. Hattori, K. Kawabata, K. Hara, D. Nakatsubo, S. Maesawa, Y. Kajita, T. Wakabayashi, M. Katsuno, G. Sobue (Nagoya, Japan)
Clinical differences between Parkinson’s disease motor phenotypes. Results from the COPPADIS Study Cohort

I. Legarda Ramirez, B. Vives Pastor, M. Menéndez González, M. Blázquez Estrada, M. Seijo, M. Lage Castro, R. Vázquez Gómez, J. Ruíz Martínez, A. Bergareche Yarza, C. Valero, MM. Kurtis, JR. Pérez Sánchez, O. de Fábregues-Boixar, J. González Ardura, C. Prieto, C. Ordás Bandera, P. Mir, P. Martínez Martín, D. Santos García (Palma de Mallorca, Spain)
Clinical effectiveness of a highly challenging balance training (HiBalance program) for Parkinson’s disease: A multi-center clinical effectiveness trial

B. Leavy, C. Joseph, N. Löfgren, H. Johansson, M. Hagströmer, E. Franzén (Stockholm, Sweden)
Clinical effectiveness of cerebellar repetitive transcranial magnetic stimulation (rTMS) on essential tremor

N. Olfati, A. Shoeibi, E. Abdollahian, V. Vakili, H. Ahmadi, H. Masoudian, A. Hoseini, M. Foroughipour, F. Rezaeitalab, M. Farzadfard, P. Layegh, S.H. Naseri (Mashhad, Islamic Republic of Iran)
Clinical evaluation of genetic changes of polymerase chain reaction in patients with PD at early stage

M. Salokhiddinov (Tashkent, Uzbekistan)
Clinical evaluation of insomnia in Parkinson’s disease and its effect on the quality of life of patients

M. Salokhiddinov. (Tashkent, Uzbekistan)
Clinical experiences in Whole systems Ayurveda Management of Parkinson’s Disease

P. Shankar, P. R, P. Devkumar, A. Godbole, U. Muthane (Bangalore, India)
Clinical features and natural history of pathologically-confirmed corticobasal degeneration: A Japanese validation study of CBD (J-VAC study)

I. Aiba, T. Shimohata, S. Murayama, K. Hasegawa, Y. Iwasaki, O. Yokota, H. Fujimura, M. Sakai, T. Yokota, I. Yabe, H. Takigawa, K. Sugaya, K. Mori, M. Ito, C. Ishida, M. Kobayashi, Y. Hashizume, T. Ikeuchi, M. Hasegawa, M. Yoshida, T. Komori, K. Wakabayashi, Y. Saito, A. Tokumaru, K. Sakurai, K. Nakashima (Nagoya, Japan)
Clinical features of Parkinson’s disease with and without rapid eye movement sleep behavior disorder

Y. Liu, XY. Zhu, XJ. Zhang, Y. Feng, SH. Kuo, W. Ondo, YC. Wu (Shanghai, China)
Clinical heterogeneity of excessive daytime sleepiness in Parkinson’s disease

O. Levin, O. Iakovleva, M. Poluektov (Moscow, Russian Federation)
Clinical indicators of advanced Parkinson’s disease: Evaluating diagnostic properties from retrospective analysis of multi-country, cross-sectional observational study

P. Odin, Z. Pirtosek, R. Rodriguez, P. Martinez-Martin, D. Shah, P. Kandukuri, O. Koray, J. Zamudio, Y. Bao, Y. Jalundhwala, A. Antonini (Lund, Sweden)
Clinical phenotype analysis of Parkinson’s disease associated with LRRK2 variants in Chinese Han population

C. Gu, K. Li, J. Zhang, H. Jin, Y. Ge, C. Liu (Suzhou, China)
Clinical practice of levodopa in parkinsonism

AC. Chen (Taichung, Taiwan)
Clinical predictors of screen-defined dementia in early Parkinson’s

F. Baig, M. Lawton, M. Rolinski, C. Ruffmann, T. Barber, J. Klein, C. Lo, Y. Ben-Shlomo, M. Hu (Oxford, United Kingdom)
Clinical profile and predictors of outcome in Neuroleptic malignant syndrome and Parkinsonism hyperpyrexia syndrome

R. Kandadai, P. Dutta, S. Meka, T. Syed, S. Tandra, S. Turaga, R. Borgohain (Hyderabad, India)
Clinical profiles of late-onset psychiatric patients with incidental REM sleep without atonia

H. Fujishiro, M. Okuda, K. Iwamoto, S. Miyata, Y. Torii, S. Iritani, N. Ozaki (Nagoya, Japan)
Clinical spectrum of vascular Parkinsonism: A hospital-based study in south India

J. Kuragala, J. Murthy, N. Chaudhary, s. Sharma, S. Jaiswal, Y. Reddy (Anantapur, India)
Clinical study on the correlation between Parkinson’s somatosensory evoked potentials and STN-DBS parameters

Z. Jing, Y. Xiaoxue, G. Shuzhao, S. Chunli, L. Zhanhua, (Dalian, China)
Clinical subtypes of Parkinson’s disease based on nonmotor symptoms: A cluster analysis

X. Xu, P. Chan (Beijing, China)
Clinical trial protocol: Restitution of oral transport, penetration and aspiration with nigral stimulation in Parkinson’s disease?

A. Schoellmann, L. Stoll, B. Hobl, C. Meisner, A. Gharabaghi, D. (Tuebingen, Germany)
Clinico-genetic correlation in Indian Spinocerebellar ataxia Type 1 (SCA1) patients

A. Takkar, I. Ahmed, S. Shakya, A. Srivastava (New Delhi, India)
Clonazepam for REM sleep behavior disorder in Parkinsonism: A randomized, placebo-controlled trial

C. Shin, H. Park, W. Lee, B. Jeon, H. Kim (Seoul, Republic of Korea)
Closed Loop Programming Evaluation Using External Responses for Deep Brain Stimulation (CLOVER-DBS)

F. Sasaki, G. Oyama, S. Sekimoto, R. Nakamura, T. Jo, H. Iwamuro, A. Umemura, Y. Shimo, N. Hattori (Tokyo, Japan)
Closed loop spinal cord stimulation restores locomotion and desynchronizes corticostriatal beta oscillations

A. Yadav, E. Borda, M. Nicolelis (Durham, NC, USA)
CLOVER-DBS: A Prospective, Multi-center Clinical Study with Blinding to Evaluate a Closed Loop Programming Algorithm for Directional Leads Based on External Feedback

A. Kuehn, G. Wenzel, C. Bruecke, L. Juarez Paz, K. Wynants, H. Scholtes, D. Blum (Berlin, Germany)
Coexisting CACNA1A pathogenic variant and MJD expansion in the same family

L. Leitão, C. Figueiredo, M. Santos, A.F. Brandão, A. Lopes, J. Sequeiros, I. Alonso, C. Costa (Amadora, Portugal)
Cognition and emotion regulation in early onset ataxia

M. Coenen, D. Sival, R. Brandsma, M. Tijssen, J. Spikman (Groningen, Netherlands)
Cognition related to striatal dopaminergic function in healthy subjects, in consideration to aging

H. Li, S. Hirano, S. Furakawa, K. Kojima, K. Shimizu, Y. Nakano, H. Tai, H. Mukai, T. Uno, T. Iimori, H. Matsuda, S. Kuwabara (Chiba, Japan)
Cognitive effects of SIRT6 overexpression: Emerging role of astrocytes

N. Lev, Y. Barhum (Kfar Saba, Israel)
Cognitive function impacts gait, functional mobility and falls in Fragile X-Associated Tremor/Ataxia Syndrome

J. O'Keefe, E. Robertson, B. Ouyang, D. Carns, Y. Liu, M. Swanson, B. Bernard, E. Berry-Kravis, D. Hall (Chicago, IL, USA)
Cognitive function is associated with Balance in Parkinson Disease: Cross-sectional study in Cali-Colombia

B. Munoz, J. Orozco, J. Valderrama, A. Navarro, Y. Castaño, J. Arango (Cali, Colombia)
Cognitive functions are associated with tremor severity in essential tremor

C.Y. Wei, W.K. Tsai, H.C. Lai, W.C. Chang, T. Taira (Changhua Country, Taiwan)
Cognitive Impairment and Depression in Patients with Parkinson’s Disease

XD. Qu, SS. Li (Lanzhou, China)
Cognitive impairment and neuropsychological disorders in essential tremor

J.X. Peng, N.N. LI, L. Wang, Z.J. Lu, J.Y. LI, R. Peng (Chengdu, China)
Cognitive impairment in multiple system atrophy: A Nepalese tertiary center study

R. Ojha, K. Oli (Kathmandu, Nepal)
Cognitive networks in Parkinson’s Disease Mild Cognitive Impairment: Salience Network disruption without gray matter loss

I. Aracil, F. Sampedro, J. Marin, J. Perez, H. Bejr-Kasem, S. Martinez-Horta, A. Horta, M. Boti, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)
Cognitive Reserve and Physical Activity Modulate Functional Brain Re-organisation in Premanifest Huntington’s Disease: Preliminary Evidence

M. Soloveva, S. Jamadar, G. Poudel, N. Georgiou-Karistianis (Melbourne, Australia)
Cohort profile of the Japan Dystonia Consortium: Genetic diagnosis and characteristics of movement disorders in Japan

T. Kawarai, R. Miyamoto, A. Orlacchio, R. Kaji (Tokushima, Japan)
Combination Therapy of Ellagic Acid and Mucuna Pruriens Seeds Extract Improves Rotenone Induced Behavioural, Oxidative and Mitochondrial Deficits in Mice Model of Parkinson’s Disease

D. Khatri (Pune, India)
Combined administration of A2A receptor antagonist and 5-HT1A/1B receptor agonist reverses neuroinflammation in the 6-OHDA model of Parkinson’s disease

A. Pinna, G. Costa, M. Serra, M. Morelli (Monserrato (CA), Italy)
Combined catechol-O-methyl-transferase inhibition and intrajejunal Levodopa infusion: A real-life single-centre experience

R.N. Taddei, V. Leta, A. Sauerbier, M. Parry, A. Podlewska, L. Hall, S. Tentis, P. Odin, W. Poewe, P. Dubois, D. van Warmelen, E.W. Lim, K.R. Chaudhuri (London, United Kingdom)
Combined EMG and endoscopy guided botulinum toxin injection of the longus capitis muscle in cervical dystonia with anterocaput

J. Michelis, F. Schuler, I. Debove, J. Müllner, L. Lachenmayer, E. Seifert (Bern, Switzerland)
Combined Neurite Orientation Dispersion and Density Imaging and Myelin Imaging Provide New Insights to White Matter Changes of the Neurocognitive-psychiatric Disorder in Parkinson’s Disease

C. Andica, K. Kamagata, T. Hatano, A. Saito, Y. Takenaka, T. Ogawa, G. Oyama, Y. Shimo, M. Hori, N. Hattori, S. Aoki (Tokyo, Japan)
Combining PET imaging and blood metabolomics data to improve machine learning models for Parkinson’s disease diagnosis

E. Glaab, A. Greuel, J.P. Trezzi, C. Jäger, Z. Hodak, L. Timmermann, M. Tittgemeyer, N. Diederich (Esch-sur-Alzette, Luxembourg)
Commonalities of prodromal non-motor symptoms between movement disorders

M. Moscovich, S. Heinzel, R. Postuma, R. Reilmann, T. Klockgether, H. Jacobi, G. Höglinger, D. Berg (Kiel, Germany)
Communication and Swallowing Disorders in People with Parkinson’s disease: A National Survey on Everyday Impacts and Service Access

M. Swales, D. Theodoros, A. Hill, T. Russell (St. Lucia, Australia)
Comorbid Pediatric Early Onset Ataxia and Dystonia – Is the Cerebellum Involved?

D. Sival, M. Tijssen, D. Verbeek (Groningen, Netherlands)
Comorbid REM sleep behavior disorder and impulse control disorder symptoms in early parkinson’s disease: The PPMI cohort

M.L. Fantini, F. Durif, JC. Corvol, D. Weintraub, C. Caspell-Garcia (Clermont Ferrand, France)
Comorbidity and retirement in primary focal cervical dystonia

R. Ortiz, F. Scheperjans, T. Mertsalmi, E. Pekkonen (Helsinki, Finland)
Comparative results between preoperative acute levodopa challenge test and deep brain stimulation

D. Fitas, M.J. Rosas, J. Parada Lima, C. Reis, P. Linhares, R. Vaz (Viana do Castelo, Portugal)
Comparative study of non-motor symptoms in patients with progressive supranuclear palsy and age, gender, duration of illness matched patients with Parkinson’s disease

V. Holla, C. SP, A. Lenka, A. Stezin, S. Prasad, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)
Comparative study of the cognitive and behavioral disturbances between progressive supranuclear palsy phenotypes

A. Horta-Barba, J. Pagonabarraga, S. Martinez-Horta, I. Illán, I. Aracil, J. Pérez-Pérez, B. Pascual, H. Bejr-Kasem, J. Marin, F. Sampedro, M. Botí, C. Izquierdo, A. Campolongo, J. Kulisevsky (Barcelona, Spain)
Comparing risperidone and olanzapine to tetrabenazine for the management of Huntington’s chorea

J. Schultz, J. Kamholz, P. Nopoulos, A. Killoran (Iowa City, IA, USA)
Comparison of botulinum toxin injections in forearm flexor and extensor muscles versus pure flexor muscles for the treatment of essential hand tremor (FLEX-D ET)

S. Patel, X. Yu, J. Lin, O. Hogue, T. Rasameesoraj, D. Hengartner, H. Fernandez (Cleveland, OH, USA)
Comparison of clinical characteristics and treatment outcomes of botulinum neurotoxin in routine clinical practice between hemifacial spasm with and without the Babinski-2 sign in Thai patients: An exploratory study

A. Suengtaworn, Y. Pitakpatapee, P. Soontrapa, C. Hurst, P. Srivanitchapoom (Bangkok, Thailand)
Comparison of low versus high frequency stimulation on stuttering in Parkinson’s disease patients with bilateral subthalamic nucleus deep brain stimulation

O. Jitkritsadakul, K. Boonpang, R. Bhidayasiri (Bangkok, Thailand)
Comparison of low-frequency stimulation versus high-frequency stimulation of the subthalamic nucleus on cerebral hemodynamics in Parkinson’s disease: A transcranial Doppler Study

A. Yilmaz, E. Okuyucu, T. Yildizgoren, S. Oral, M. Aras, Y. Serarslan (Hatay, Turkey)
Comparison of Mattis and MOCA testing for neuropsychological assessment in the preoperative evaluation of subthalamic nucleus stimulation in Parkinson´s disease

L. Prilop, M. Alsalem, A. Gulberti, C. Gerloff, C. Buhmann, W. Hamel, C. Moll, J. Köppen, M. Pötter-Nerger (Hamburg, Germany)
Comparison of quantitative analysis of finger and forearm movements between early stage Parkinson’s disease and scans without evidence of dopaminergic deficit (SWEDD)

D.Y. Kwon, M.H. Park, J.W. Kim (Ansan-city, Republic of Korea)
Comparison of thermal sensation and pain thresholds in LRRK2 carriers and non carriers with Parkinson’s disease

A. Khlebtovsky, Y. Roditi, R. Djaldetti (Petach Tikva, Israel)
Comparison of Treatment Effectiveness of Conventional Functional Training (CFT) to Occupational Therapy (OT) Multi-modal CASH Program (CASH) in Improving Non-motor Symptoms and Carer Stress of Parkinson’s (PD) Patient at Intermediate and Advanced State

T. Tang, R. Wong, C. Lau, A. Chan, D. Chan, X.L. Zhu, W.S. Poon, V. Mok (Hong Kong)
Comparison of virtual-reality-gaming and activity-based gait and balance training on gait, balance and quality of life in patients with Parkinson’s disease

A. Ogundele, M. Olaogun, M. Komolafe (Ile-Ife, Nigeria)
Comparison of Volumetric MRI measurements between Dementia with Lewy bodies and prodromal Lewy body disease

B. Tousi, F. Flanigan, k. Khosravi (Cleveland, OH, USA)
Comparisons of cerebral glucose metabolism and striatal DAT binding in PD patients with and without RBD

P. Wu, Q. Xu, J. Wang, C. Zuo (Shanghai, China)
Compensation strategies for gait impairments in Parkinson’s disease

J. Nonnekes, E. Růžička, A. Nieuwboer, M. Hallett, A. Fasano, B. Bloem (Nijmegen, Netherlands)
Compensatory functional activations in early-stage Parkinson’s disease: a cross-sectional motor planning fMRI study

A. Martin-Bastida, N. Lao-Kaim, S. Pietracupa, A. Roussakis, Y. Xing, S. Schwarz, D. Auer, P. Piccini (London, United Kingdom)
Complementary value of MRI-based differential diagnosis in parkinsonism

S. Kim, E. Oh, Y. Lim, J. Ham, J. Lee, E. Sohn, A. Lee (Daejeon, Republic of Korea)
Compound-heterozygous mutations in VPS13D are a novel cause of spastic ataxia and lead to mitochondrial dysfunction

M. Dulovic, N. Brüggemann, J. Trinh, A. Münchau, C. Klein, K. Lohmann (Luebeck, Germany)
Computational and Biochemical analysis of lipid raft proteins: A new perspective approach to understand the progression of late onset Parkinson’s disease

L. Thangamani, S. Piramanayagam (Coimbatore, India)
Connectivity profile of delayed-onset DBS side effects

M. Reich, J. Hsu, J. Joutsa, J. Roothans, N. Pozzi, J. Volkmann, I. Isaias, M. Fox (Boston, MA, USA)
Consensus for the measurement of the camptocormia angle

N. Margraf, R. Wolke, O. Granert, A. Berardelli, D. Berg, B. Bloem, R. Djaldetti, A. Espay, A. Fasano, Y. Furusawa, N. Giladi, M. Hallett, J. Jankovic, M. Murata, M. Tinazzi, J. Volkmann, G. Deuschl (Kiel, Germany)
Contingent negative variation in patients with cervical dystonia related to sensory tricks

HW. Shin, HJ. Cho, SW. Lee, M. Hallett (Seoul, Republic of Korea)
Contribution of ATP-sensitive potassium channels in the subthalamic nucleus neurons towards Parkinson’s disease

C. Mahapatra, R. Manchanda (Mumbai, India)
Contribution of individual motor signs to striatal dopamine deficiency in parkinsonism

E. Mäkinen, J. Joutsa, E. Jaakkola, T. Noponen, J. Johansson, M. Pitkonen, R. Levo, T. Mertsalmi, F. Scheperjans, V. Kaasinen (Turku, Finland)
Contribution of the French registry in the understanding of Wilson disease

A. Poujois, N. Girardot, A.S. Brunet, A. Lachaux, F. Woimant (Paris, France)
Controlled neural organoids grafting promotes functional recovery in experimental parkinsonism

E. Faggiani, M. Feyeux, K. Alessandri, P. Cohen, E. Pioli, F. Naudet, A. Benazzzouz, P. Nassoy, E. Bezard (Bordeaux, France)
Correlation between cerebral perfusion and striatal dopamine transporter activity by dual SPECT study in Parkinsonian syndromes

Y. Nakano, S. Hirano, K. Kojima, H. Li, A. Ishikawa, T. Sakurai, H. Tai, H. Mukai, T. Horikoshi, T. Uno, S. Kuwabara (Chiba, Japan)
Correlation between mood and behavioral disorders and quality of life in patients with Parkinson’s disease

O. Galceava, A. Mita, L. Giurgiulescu, R. Latea, V. Tudorica, D. Gheonea, D. Stanca (Craiova, Romania)
Correlation between severity of disease, spatio-temporal variables, and kinematic variables during forward and backward walking

M. Son, C. Youm, M. Lee, H. Park (Busan, Republic of Korea)
Cortical and brainstem neurodegeneration associate with the clinical severity in spinocerebellar ataxia patients

D. Tamuli, M. Kaur, S. Kumaran, A. Jaryal, A. Srivastava, K. Deepak (New Delhi, India)
Cortical correlates of dual-task turning with and without freezing of gait

M. Mancini, S. Stuart (Portland, OR, USA)
Cortical myoclonus explained by cerebellar dysfunction: Evidence from a unique case

L. Rocchi, L. Latorre, J. Rothwell, K. Bhatia (London, United Kingdom)
Cortical thinning as a neuroimaging marker of cognitive decline in X-linked dystonia-parkinsonism

J. Prasuhn, H. Hanßen, A. Domingo, C. Diesta, R. Rosales, R. Jamora, C. Klein, N. Brüggemann (Luebeck, Germany)
Corticobasal Syndrome: A Single Center Case Series

M. Siddiqui, C. Goas (Winston Salem, NC, USA)
Corticomuscular and Intermuscular Coherence as a Biomarker of Pallidal Deep Brain Stimulation Efficacy in Dystonia

E. Doldersum, J. van Zijl, M. Beudel, H. Eggink, R. Brandsma, D. Pina Fuentes, M. van Egmond, D. Oterdoom, J. van Dijk, J. Elting, M. de Koning-Tijssen (Groningen, Netherlands)
Costs and outcomes for Parkinson’s disease patients who have their management adjusted by Personal KinetiGraph (PKG)

P. Lynch, D. Jackson, D. Tilden, M. Horne (Minnetonka, MN, USA)
Could curcumin be the preventive key of parkinson’s disease?

W. Laabbar, A. Elgot, H. Gamrani (Marrakech, Morocco)
Could the rate of dopaminergic medications reduction affect outcome after STN-DBS?

S. Alusi (Liverpool, United Kingdom)
Crack Dancing: An Uncommon Drug-Induced Chorea

G. Gibb, D. Nacopoulos (Erie, PA, USA)
Creating a safe home for Parkinson’s disease patients: Designed principles for modifications

T. Jantanapornchai, J. Sringean, S. Pensook, P. Sankham, N. Kantachadvanich, S. Phumphid, R. Bhidayasiri (Bangkok, Thailand)
CRISPR/Cas9-based fluorescent tyrosine hydroxylase-reporter lines

A. Rakovic, F. Vulinovic, C. Klein (Lübeck, Germany)
Curcumin improves cognitive function in rotenone-induced rat model of Parkinson’s disease (PD)

S. Madiha, S. Haider (Karachi, Pakistan)